21 Stock and 79 ETF Taysha Gene Therapies (TSHA) alternatives
The most close Taysha Gene Therapies (TSHA) alternative is ETF QBTX (TRADR 2X LONG QBTS DAILY ETF). The correlation is 0.8272.
Stocks that highly correlated with TSHA
| Symbol | Name | Market cap | Sector | Industry | Correlation |
|---|---|---|---|---|---|
| AURC | Better Home & Finance Holding Co. - Class A | $104M | N/A | N/A | 0.78 |
| HVMCU | Highview Merger Corp - Units (1 Ord Cls A & 1/2 War) | $52M | Financial Services | Shell Companies | 0.75 |
| PONY | Pony AI Inc | $2.72B | Technology | Information Technology Services | 0.74 |
| GTERR | Globa Terra Acquisition Corporation Rights | $407K | N/A | N/A | 0.74 |
| CCCX | Churchill Capital Corp X - Class A | $570M | Financial Services | Shell Companies | 0.73 |
| BACQR | Merlin Inc | $52M | N/A | N/A | 0.71 |
| PLT | N/A | $508M | N/A | N/A | 0.71 |
| SOUL | Soul Vibe Interactive Inc | $266M | Financial Services | Shell Companies | 0.69 |
| NUTR | Nusatrip Inc | $174M | Consumer Cyclical | Travel Services | 0.68 |
| FMST | Foremost Clean Energy Ltd New | $24M | Basic Materials | Other Industrial Metals & Mining | 0.66 |
| ATHR | Aether Holdings Inc | $53M | Technology | Software - Application | 0.65 |
| SSEAU | Starry Sea Acquisition Corp - Units (1 Ord Shs & 1/6 Rts) | $19M | Financial Services | Shell Companies | 0.64 |
| HVII | N/A | $199M | Financial Services | Shell Companies | 0.64 |
| RWTO | Redwood Trust Inc | $3.06B | N/A | N/A | 0.63 |
| ALPS | Alpine Summit Energy Partners Inc | $24M | N/A | Oil & Gas | 0.62 |
| BIYA | Baiya International Group Inc | $620K | Technology | Software - Application | 0.62 |
| SBET | SharpLink Gaming Inc | $1.21B | Financial Services | Capital Markets | 0.60 |
| ABVE | Above Food Ingredients Inc | $66M | Consumer Defensive | Packaged Foods | 0.60 |
| FLD | Fold Holdings Inc - Class A | $23M | Financial Services | Capital Markets | 0.60 |
| KIDZ | Classover Holdings Inc | $2.67M | Consumer Defensive | Education & Training Services | 0.59 |
| SEPN | Septerna Inc | $1.53B | Healthcare | Biotechnology | 0.59 |